logo white

From bench to bedside

Research Menu

Principal Scientist, Dr Elham Beheshti’s focus is on fostering patient-centric research and translating our discoveries into practical solutions.

We are dedicated to bridging the gap between the laboratory and real-world impact, with a steadfast commitment to addressing the needs of those affected by asbestos and dust related diseases. These efforts will cultivate a culture of growth, innovation, and collaboration, propelling our research centre toward a brighter future.

Elham’s vision for our research team is to continually strive for improvement. While acknowledging our strengths is crucial, it is equally important to identify areas where we have room to excel further. By recognizing these areas, we can proactively address our weaknesses and evolve as a united and formidable unit.

“I am dedicated to nurturing specialised expertise within each member of our research team, providing the support needed to help everyone reach their full potential. Additionally, I am deeply committed to enhancing our research governance, ensuring that our work is conducted with the utmost integrity, efficiency, and impact.
I am actively working to strengthen our relationships with clinicians, medical scientists, pharmaceutical companies, and venture capital firms. This collaborative approach will not only help us identify unmet needs but also facilitate the development of innovative solutions to address them. Together, we have the power to make a significant difference in the world of research and healthcare, and I am excited about the positive impact we will create.”

Grants led by Dr Elham Hosseini Beheshti:

Medical Research Future Fund – MTPConnect REDI Program

Project Summary

This grant will embed Dr Beheshti at IP Group within a team of investment managers to receive hands-on experience on the commercialisation of ground-breaking research within Australasia.

Grant amount

$200,366 + January – December 2023

Key Achievements

During this fellowship, I have had the opportunity of reviewing programs across multiple research fields. Additionally, I have actively engaged with industry professionals and field experts, allowing me to gain valuable insights into emerging areas of interest within pharmaceutical industry.

 

NHMRC Ideas Grant ‘Unlocking the potential of cancer associated fibroblasts to defeat pancreatic cancer'

Project Summary

Dr Elham is Chief Investigator B

Grant amount

$636,920

Key Achievements

A PhD student has been successfully recruited for this project, and I will be serving as the Co-supervisor for the student. The project is scheduled to commence in 2024.

 

 

DDB Discovery Research Grant– ‘Extracellular Vesicles, a Gateway to Precision Medicine: Immunotherapy in Mesothelioma'

Project Summary

Dr Elham is Chief Investigator A

Grant amount

$470,000 – over three years

Key Achievements

Grant is on pause for 2023 while Dr Elham participates in REDI Program

 

 

Pankind (The Australian Pancreatic Cancer Foundation) 2023

Project Summary

Dr Elham is Chief Investigator C

Grant amount

$99,077 – 2023

 

USyd-UEdin Partnership Collaboration Awards ‘Development of a self-powered dye sensitized solar cell sensor as a point of care (POC) device for portable and fast extracellular vesicles (EV) based cancer diagnosis'

Project Summary

Dr Elham is Chief Investigator A

Grant amount

$20,000 – consumables have come to ADDRI.

Key Achievements

The initial phase of the project has been successfully completed with the development of a self-powered dye-sensitized solar cell sensor at UEdin in collaboration with Dr Elham. The first manuscript detailing the findings has been completed and is set to be submitted shortly. In September, Elham will meet with Dr Chen to review the project’s progress and explore opportunities for future collaborations with the team.

 

 

Turner Freeman Lawyers Donation ‘Extracellular Vesicles in Mesothelioma'

Project Summary

Dr Elham is Chief Investigator A

Grant amount

$25,000

 

The Ruth Rose, David Doust, and Debbie Brewer Gift ‘Understanding the Role of Extracellular Vesicles in Mesothelioma Tumour’

Project Summary

Dr Elham is Chief Investigator A

Grant amount

$120,000

Key Achievements

We have successfully completed several major experiments focusing on multi-omics analysis of EV cargo, as well as RNAseq analysis concerning the role of EV in the tumour microenvironment (TME). Presently, we are in the process of preparing additional samples to be sent for future analysis, which will be carried out by the EV postdoc. These ongoing investigations hold great promise and are expected to significantly contribute to our understanding of EV functions and their implications in the TME.

 

Sign up to our newsletter

Sign up
Skip to content